Suchergebnisse - "Hypoxia"

PubPharm (7.558)

81

Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4′,5-trimethoxylstilbene-3′-O-phosphate disodium (M410)

enthalten in: Investigational new drugs | 2009

von Cai, Y. | Zou, Y. | Ye, Y. | +5

82

Nicotinamide prevents the long-term effects of perinatal asphyxia on apoptosis, non-spatial working memory and anxiety in rats

enthalten in: Experimental brain research | 2009

von Morales, P. | Simola, N. | Bustamante, D. | +6

83

Nicotinamide prevents the long-term effects of perinatal asphyxia on apoptosis, non-spatial working memory and anxiety in rats

enthalten in: Experimental brain research | 2009

von Morales, P. | Simola, N. | Bustamante, D. | +6

84

Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4′,5-trimethoxylstilbene-3′-O-phosphate disodium (M410)

enthalten in: Investigational new drugs | 2009

von Cai, Y. | Zou, Y. | Ye, Y. | +5

85

Nicotinamide prevents the long-term effects of perinatal asphyxia on apoptosis, non-spatial working memory and anxiety in rats

enthalten in: Experimental brain research | 2009

von Morales, P. | Simola, N. | Bustamante, D. | +6

86

Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4′,5-trimethoxylstilbene-3′-O-phosphate disodium (M410)

enthalten in: Investigational new drugs | 2009

von Cai, Y. | Zou, Y. | Ye, Y. | +5

87

Expression of HIF-1alpha and VEGF in colorectal cancer : association with clinical outcomes and prognostic implications

enthalten in: BMC cancer | 2009

von Cao, D. | Hou, M. | Guan, Y. | +3

88

The effects of HIF-1alpha on gene expression profiles of NCI-H446 human small cell lung cancer cells

enthalten in: Journal of experimental & clinical cancer research : CR | 2009

von Wan, J. | Ma, J. | Mei, J. | +1

89

Molecular markers of yolk sac fry development in nine families of lake trout

enthalten in: Journal of aquatic animal health | 2009

von Vuori, K. | Paavilainen, T. | Nikinmaa, M. | +2

90

A phase I trial of PR-104, a nitrogen mustard prodrug activated by both hypoxia and aldo-keto reductase 1C3, in patients with solid tumors

enthalten in: Cancer chemotherapy and pharmacology | 2009

von Jameson, M. | Rischin, D. | Pegram, M. | +4